Eletrorretinograma multifocal em pacientes tratadas com tamoxifeno em baixa dosagem
Autor(a) principal: | |
---|---|
Data de Publicação: | 2004 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Repositório Institucional da UNIFESP |
Texto Completo: | http://dx.doi.org/10.1590/S0004-27492004000400013 http://repositorio.unifesp.br/handle/11600/2161 |
Resumo: | PURPOSE: Tamoxifen, an antiestrogen, has been used as an effective therapeutic agent in the treatment of breast cancer. The drug has been shown to cause ocular toxic effects. The purpose of this study was to determine possible central retinal toxicity by multifocal electroretinograms (mfERGs) in a cohort of patients treated with low-dose tamoxifen (20 mg/day) for breast cancer. METHODS: Multifocal electroretinograms of the central 30 degrees of the retina were obtained of 3 different groups: Experimental group - 15 females (41-59 years, mean 48.6 ± 4.5) with normal fundus, treated with low-dose tamoxifen for 1 to 55 months. Control group - 6 females (30-76 years, mean 49.9 ± 18.8) with previous breast cancer diagnosis who had not received tamoxifen as treatment until ERG testing. Normal control group - 15 normal female volunteers (30-71 years, mean 47.7 ± 12.9). The multifocal amplitude and latency for N1-P1 were measured and statistically analyzed (one-way ANOVA). RESULTS: Mean amplitudes N1-P1 (nV/deg²) were comparable for responses of different eccentricity (0 to 25 degrees). There was no statistically significant difference for implicit time of N1 and P1 (ms) in multifocal electroretinograms between the 3 groups. CONCLUSIONS: Low-dose tamoxifen showed no retinotoxic effect in this small group of women with breast cancer. Follow-up investigation could provide a better understanding of these effects. |
id |
UFSP_449222623e58e95ce14d3c47bf620a5e |
---|---|
oai_identifier_str |
oai:repositorio.unifesp.br/:11600/2161 |
network_acronym_str |
UFSP |
network_name_str |
Repositório Institucional da UNIFESP |
repository_id_str |
3465 |
spelling |
Eletrorretinograma multifocal em pacientes tratadas com tamoxifeno em baixa dosagemMultifocal ERG in patients treated with low-dose tamoxifenBreast neoplasmsTamoxifenRetinaElectroretinographyNeoplasias mamáriasTamoxifenoRetinaEletrorretinografiaPURPOSE: Tamoxifen, an antiestrogen, has been used as an effective therapeutic agent in the treatment of breast cancer. The drug has been shown to cause ocular toxic effects. The purpose of this study was to determine possible central retinal toxicity by multifocal electroretinograms (mfERGs) in a cohort of patients treated with low-dose tamoxifen (20 mg/day) for breast cancer. METHODS: Multifocal electroretinograms of the central 30 degrees of the retina were obtained of 3 different groups: Experimental group - 15 females (41-59 years, mean 48.6 ± 4.5) with normal fundus, treated with low-dose tamoxifen for 1 to 55 months. Control group - 6 females (30-76 years, mean 49.9 ± 18.8) with previous breast cancer diagnosis who had not received tamoxifen as treatment until ERG testing. Normal control group - 15 normal female volunteers (30-71 years, mean 47.7 ± 12.9). The multifocal amplitude and latency for N1-P1 were measured and statistically analyzed (one-way ANOVA). RESULTS: Mean amplitudes N1-P1 (nV/deg²) were comparable for responses of different eccentricity (0 to 25 degrees). There was no statistically significant difference for implicit time of N1 and P1 (ms) in multifocal electroretinograms between the 3 groups. CONCLUSIONS: Low-dose tamoxifen showed no retinotoxic effect in this small group of women with breast cancer. Follow-up investigation could provide a better understanding of these effects.OBJETIVO: O tamoxifeno é um antiestrógeno utilizado como agente terapêutico eficaz no câncer de mama. A droga pode causar efeitos tóxicos oculares em dosagens altas. O objetivo deste estudo foi determinar possíveis efeitos retino-tóxicos centrais usando o eletrorretinograma multifocal (mfERG) em grupo de pacientes tratadas com baixa dosagem de tamoxifeno (20 mg/dia) após cirurgia do câncer de mama. MÉTODOS: O eletrorretinograma multifocal (mfERG) de 30 graus centrais da retina foi obtido em 3 diferentes grupos: Grupo experimental - 15 mulheres (41-59 anos, média 48,6 ± 4,5) com fundo de olho normal, tratadas com tamoxifeno em baixa dosagem por 1 a 55 meses. Grupo controle - 6 mulheres (30 -76 anos, média 49,9±18,8) com diagnóstico prévio de câncer de mama que não receberam tratamento com tamoxifeno até o teste do eletrorretinograma multifocal. Grupo controle normal - 15 voluntárias normais (30-71 anos, média 47,7 ± 12,9). A amplitude e a latência de eletrorretinograma multifocal para N1-P1 foram analisados estatisticamente (análise de variância de uma via). RESULTADOS: As amplitudes médias N1-P1 (nV/grau²) foram comparáveis para respostas de diferentes excentricidades (0 a 25 graus) nos três grupos. Não houve diferença estatisticamente significativa para a latência de N1 e P1 (ms) do eletrorretinograma multifocal entre os 3 grupos. CONCLUSÕES: O tratamento com baixa dosagem de tamoxifeno não mostrou efeitos retino-tóxicos em pequeno grupo de mulheres após cirurgia do câncer de mama. Investigação seriada proporcionará melhor compreensão desses efeitos.Universidade Federal de São Paulo (UNIFESP) Departamento de OftalmologiaUniversidade Federal de São Paulo (UNIFESP) Departamento de Oftalmologia Setor de Eletrofisiologia Visual ClínicaHospital do Câncer - AC. CamargoUNIFESP, Depto. de OftalmologiaUNIFESP, Depto. de Oftalmologia Setor de Eletrofisiologia Visual ClínicaSciELOConselho Brasileiro de OftalmologiaUniversidade Federal de São Paulo (UNIFESP)Hospital do Câncer - AC. CamargoBerezovsky, Adriana [UNIFESP]Salomão, Solange Rios [UNIFESP]Pereira, Josenilson Martins [UNIFESP]Sacai, Paula Yuri [UNIFESP]Chojniak, Márcia Maria Motono2015-06-14T13:31:12Z2015-06-14T13:31:12Z2004-08-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion631-635application/pdfhttp://dx.doi.org/10.1590/S0004-27492004000400013Arquivos Brasileiros de Oftalmologia. Conselho Brasileiro de Oftalmologia, v. 67, n. 4, p. 631-635, 2004.10.1590/S0004-27492004000400013S0004-27492004000400013.pdf0004-2749S0004-27492004000400013http://repositorio.unifesp.br/handle/11600/2161porArquivos Brasileiros de Oftalmologiainfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-08-04T12:27:25Zoai:repositorio.unifesp.br/:11600/2161Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-08-04T12:27:25Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false |
dc.title.none.fl_str_mv |
Eletrorretinograma multifocal em pacientes tratadas com tamoxifeno em baixa dosagem Multifocal ERG in patients treated with low-dose tamoxifen |
title |
Eletrorretinograma multifocal em pacientes tratadas com tamoxifeno em baixa dosagem |
spellingShingle |
Eletrorretinograma multifocal em pacientes tratadas com tamoxifeno em baixa dosagem Berezovsky, Adriana [UNIFESP] Breast neoplasms Tamoxifen Retina Electroretinography Neoplasias mamárias Tamoxifeno Retina Eletrorretinografia |
title_short |
Eletrorretinograma multifocal em pacientes tratadas com tamoxifeno em baixa dosagem |
title_full |
Eletrorretinograma multifocal em pacientes tratadas com tamoxifeno em baixa dosagem |
title_fullStr |
Eletrorretinograma multifocal em pacientes tratadas com tamoxifeno em baixa dosagem |
title_full_unstemmed |
Eletrorretinograma multifocal em pacientes tratadas com tamoxifeno em baixa dosagem |
title_sort |
Eletrorretinograma multifocal em pacientes tratadas com tamoxifeno em baixa dosagem |
author |
Berezovsky, Adriana [UNIFESP] |
author_facet |
Berezovsky, Adriana [UNIFESP] Salomão, Solange Rios [UNIFESP] Pereira, Josenilson Martins [UNIFESP] Sacai, Paula Yuri [UNIFESP] Chojniak, Márcia Maria Motono |
author_role |
author |
author2 |
Salomão, Solange Rios [UNIFESP] Pereira, Josenilson Martins [UNIFESP] Sacai, Paula Yuri [UNIFESP] Chojniak, Márcia Maria Motono |
author2_role |
author author author author |
dc.contributor.none.fl_str_mv |
Universidade Federal de São Paulo (UNIFESP) Hospital do Câncer - AC. Camargo |
dc.contributor.author.fl_str_mv |
Berezovsky, Adriana [UNIFESP] Salomão, Solange Rios [UNIFESP] Pereira, Josenilson Martins [UNIFESP] Sacai, Paula Yuri [UNIFESP] Chojniak, Márcia Maria Motono |
dc.subject.por.fl_str_mv |
Breast neoplasms Tamoxifen Retina Electroretinography Neoplasias mamárias Tamoxifeno Retina Eletrorretinografia |
topic |
Breast neoplasms Tamoxifen Retina Electroretinography Neoplasias mamárias Tamoxifeno Retina Eletrorretinografia |
description |
PURPOSE: Tamoxifen, an antiestrogen, has been used as an effective therapeutic agent in the treatment of breast cancer. The drug has been shown to cause ocular toxic effects. The purpose of this study was to determine possible central retinal toxicity by multifocal electroretinograms (mfERGs) in a cohort of patients treated with low-dose tamoxifen (20 mg/day) for breast cancer. METHODS: Multifocal electroretinograms of the central 30 degrees of the retina were obtained of 3 different groups: Experimental group - 15 females (41-59 years, mean 48.6 ± 4.5) with normal fundus, treated with low-dose tamoxifen for 1 to 55 months. Control group - 6 females (30-76 years, mean 49.9 ± 18.8) with previous breast cancer diagnosis who had not received tamoxifen as treatment until ERG testing. Normal control group - 15 normal female volunteers (30-71 years, mean 47.7 ± 12.9). The multifocal amplitude and latency for N1-P1 were measured and statistically analyzed (one-way ANOVA). RESULTS: Mean amplitudes N1-P1 (nV/deg²) were comparable for responses of different eccentricity (0 to 25 degrees). There was no statistically significant difference for implicit time of N1 and P1 (ms) in multifocal electroretinograms between the 3 groups. CONCLUSIONS: Low-dose tamoxifen showed no retinotoxic effect in this small group of women with breast cancer. Follow-up investigation could provide a better understanding of these effects. |
publishDate |
2004 |
dc.date.none.fl_str_mv |
2004-08-01 2015-06-14T13:31:12Z 2015-06-14T13:31:12Z |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1590/S0004-27492004000400013 Arquivos Brasileiros de Oftalmologia. Conselho Brasileiro de Oftalmologia, v. 67, n. 4, p. 631-635, 2004. 10.1590/S0004-27492004000400013 S0004-27492004000400013.pdf 0004-2749 S0004-27492004000400013 http://repositorio.unifesp.br/handle/11600/2161 |
url |
http://dx.doi.org/10.1590/S0004-27492004000400013 http://repositorio.unifesp.br/handle/11600/2161 |
identifier_str_mv |
Arquivos Brasileiros de Oftalmologia. Conselho Brasileiro de Oftalmologia, v. 67, n. 4, p. 631-635, 2004. 10.1590/S0004-27492004000400013 S0004-27492004000400013.pdf 0004-2749 S0004-27492004000400013 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
Arquivos Brasileiros de Oftalmologia |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
631-635 application/pdf |
dc.publisher.none.fl_str_mv |
Conselho Brasileiro de Oftalmologia |
publisher.none.fl_str_mv |
Conselho Brasileiro de Oftalmologia |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UNIFESP instname:Universidade Federal de São Paulo (UNIFESP) instacron:UNIFESP |
instname_str |
Universidade Federal de São Paulo (UNIFESP) |
instacron_str |
UNIFESP |
institution |
UNIFESP |
reponame_str |
Repositório Institucional da UNIFESP |
collection |
Repositório Institucional da UNIFESP |
repository.name.fl_str_mv |
Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP) |
repository.mail.fl_str_mv |
biblioteca.csp@unifesp.br |
_version_ |
1814268341792014336 |